pre-ipo
Stage
2006
Founded
2
Investors
About
Olema is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and other solid tumors.
Explore Olema's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.